期刊文献+

促红细胞生成素对幼兔心肌缺血再灌注损伤的实验研究 被引量:3

Effect of Erythropoietin on Myocardial Ischemia-reperfusion Injury in Immature Rabbits
下载PDF
导出
摘要 目的研究不同剂量促红细胞生成素(EP0)对幼兔心肌缺血再灌注损伤的保护作用。方法32只幼兔随机分成对照组(A组)、3 000 U/kg EP0预处理组(B组)、5 000 U/kg EP0预处理组(C组)和7 000 U/kg EP0预处理组(D组),每组8只。B、C、D组均提前24 h腹腔注射EPO,A组腹腔注射2 ml生理盐水。建立Langendorff幼兔离体心脏灌注模型,测定缺血前和缺血再灌注120 min时的冠状动脉流量、心排血量、左心室收缩压和左心室舒张期末压。收集缺血再灌注60 min时的冠脉流液2 ml,检测肌酸激酶和乳酸脱氢酶的含量。取缺血再灌注后心肌,测定心肌含水量、心肌丙二醛含量、心肌三磷酸腺苷及磷酸肌酸含量;测定缺血前和缺血再灌注120 min时心肌细胞线粒体Na+,K+-ATP酶和Ca2+-ATP酶的活性。结果缺血再灌注后B、C、D组心功能恢复明显优于A组(P<0.05)。B、C、D组的心肌含水量及心肌乳酸脱氢酶、肌酸激酶、丙二醛含量均显著低于A组(P<0.05),B、C、D组心肌三磷酸腺苷、磷酸肌酸含量及心肌细胞线粒体Na+,K+-ATP酶和Ca2+-ATP酶的活性均显著高于A组(P<0.05)。C、D两组间比较,各项生化指标及心功能恢复均无显著性差异,但C、D组的心肌保护作用明显优于B组(P<0.05)。结论EPO预处理可显著降低未成熟心肌缺血再灌注损伤,具有良好的心肌保护作用。 Objective To study the protective effect of erythropoietin (EPO) on myocardial ischemia-reperfusion (I/R) injury in immature rabbits. Methods Thirty-two immature rabbits were randomly divided into 4 groups (n =8 each group). The rabbits were intraperiloneally injected with 2 ml of normal saline in group A, 3 000 U/kg of EPO in group B, 5 000 U/kg of EPO in group C, and 7 000 U/kg of EPO in group D 24 h before I/R, respectively. The Langendorff isolated perfused heart model was established, and the coronary flow, cardiac output, left ventricular systolic pressure, and left ventricular end-diastolic pressure before ischemia and 120 minutes after repeffusion were determined. The contents of creatine kinase and lactate dehydrogenase in coronary blood flow were measured 60 minutes after reperfusion. The myocardial water content and the contents of malondialdehyde,adenosine triphosphate,and creatine phosphate in the myoeardium were detected 120 minutes after reperfusion. The activities of Na^+, K^+-ATPase and Ca^2+-ATPase in myocardial mitoehondria were detected before ischemia and 120 minutes after repeffusion. Results The recovery of cardiac function in groups B,C,and D were better than that in group A (P 〈 0.05 ). Compared with group A, the myocardial water content and the contents of lactate dehydrogenase, creatine kinase, and malondialdehyde in the myocardium were significantly lower and the contents of adenosine triphosphate and ereatine phosphate and the activities of Na^+, K^+- ATPase and Ca^2+-ATPse in myocardial mitochondria significantly higher in groups B, C, and D (all P 〈 0.05 ). There was no significant difference in the biochemical indexes and the recovery of cardiac function between groups C and D, but the protective effect of EPO agaisnt myocardial I/R injury in groups C and D was better than that in group B (P 〈 0.05 ). Conclusion EPO pretreatment significantly reduces the myocardial I/R injury in immature rabbits, and better protective effect on myocardium c
出处 《中国医科大学学报》 CAS CSCD 北大核心 2009年第6期431-433,436,共4页 Journal of China Medical University
基金 辽宁省教育厅高校科学研究计划项目(05L486)
关键词 促红细胞生成素 心肌缺血再灌注损伤 未成熟心肌保护 预处理 erythropoietin myocardial ischemia-reperfusion injury immature myocardial protection pretreatment
  • 相关文献

参考文献6

  • 1耿庆,高尚志.兔未成熟心肌增龄性变化及成熟时限的研究[J].中华实验外科杂志,2000,17(3):251-252. 被引量:23
  • 2Ihnken K. Myocardial protection in hypoxie immature heart [J].J Thorae Cardiovasc Surg, 2000,48 ( 1 ) : 46-54. 被引量:1
  • 3Bahlmana FH, de Groot K, Haller H, et al, Erythropoietin : is it more than correcting anaemia? [J]. NephroI Dial Transplant,2004,19 ( 1 ) : 20-22. 被引量:1
  • 4Hirata A, Minanino T, Asanuma H, et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs [J ]. J Am Coll Cardiol, 2006,48 ( 1 ) : 176-184. 被引量:1
  • 5Nishiya D,Omura T,Shimada K,et al. Effects of erythropoietin on cardiac remodeling after myocardial infarction [J ]. J Pharmacol Sci, 2006,101 ( 1 ) : 31-39. 被引量:1
  • 6Kis A, Yellon DM, Baxter GF. Second window of protection following myocardial preconditioning:an essential role for PI3 kinase and p70S6 kinase [JJ. J Mol Cell Cardiol,2003,35(9) : 1063-1071. 被引量:1

二级参考文献2

共引文献22

同被引文献38

  • 1杜晓英,陈江华.促红细胞生成素与肾缺血再灌注损伤[J].国外医学(移植与血液净化分册),2005,3(4):8-11. 被引量:7
  • 2孙晓杰,黄常志.PI3K-Akt信号通路与肿瘤[J].世界华人消化杂志,2006,14(3):306-311. 被引量:81
  • 3周春燕,陈玉培.PI3K/AKT信号通路在异丙酚减轻离体大鼠心脏缺血再灌注损伤中的作用[J].中华麻醉学杂志,2007,27(2):152-155. 被引量:3
  • 4Abe J, Baines CP, Berk BC. Role of mitogen-activated protein kinases in ischemia and reperfusion injury:the good and the bad [J]. Circ Res, 2000,86 (6) : 692-699. 被引量:1
  • 5Hirata A,Minanino T,Asanuma H,et al. Erythropoietin enhances neovascularization of ischemic myocardium and improves left ventricular dysfunction after myocardial infarction in dogs[J]. J Am Coll Cardiol, 2006,4 : 176-184. 被引量:1
  • 6Matsui T, Nagoshi T, Rosenzweig A. Akt and PI3 kinase signaling in cardiac hypertrophy and survival[J]. Cell Cycle,2003,2(3) :220-223. 被引量:1
  • 7Kennedy SG, Wagner A J, Conzen SD ,et al.The PI3-kinase/Akt sig naling pathway delivers an anti-apoptotic signal[ J ]. Genes Dev, 1997, 11(6):701-713. 被引量:1
  • 8Tsang A, Hauseuloy D J, Moeanu MM, et al. Posteonditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway [ J ]. Circ Res,2004,95 ( 3 ) : 230-232. 被引量:1
  • 9Zhou HL,Li XM,Meinkoth J,et al. Akt regulates cell survival and apoptosis at a postmitochondrial level[ J ]. J Cell Biol, 2000,151 (3) : 483-494. 被引量:1
  • 10Ruifrok WP,de Boer RA,Westenbrink BD,et al.Erythropoietin in cardiac disease:New features of an old drug [ J ]. Eur J Pharmacol, 2008,585 ( 2-3 ) : 270-277. 被引量:1

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部